169 related articles for article (PubMed ID: 33871409)
1. Beyond T Staging in the "Treat-All" Era: Severity and Heterogeneity of Kaposi Sarcoma in East Africa.
Freeman EE; Semeere A; McMahon DE; Byakwaga H; Laker-Oketta M; Regan S; Wenger M; Kasozi C; Ssemakadde M; Bwana M; Kanyesigye M; Kadama-Makanga P; Rotich E; Kisuya J; Wools-Kaloustian K; Bassett IV; Busakhala N; Martin J
J Acquir Immune Defic Syndr; 2021 Aug; 87(5):1119-1127. PubMed ID: 33871409
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of Rapid Case Ascertainment for Cancer in East Africa: An Investigation of Community-Representative Kaposi Sarcoma in the Era of Antiretroviral Therapy.
Semeere A; Byakwaga H; Laker-Oketta M; Freeman E; Busakhala N; Wenger M; Kasozi C; Ssemakadde M; Bwana M; Kanyesigye M; Kadama-Makanga P; Rotich E; Kisuya J; Sang E; Maurer T; Wools-Kaloustian K; Kambugu A; Martin J
Cancer Epidemiol; 2021 Oct; 74():101997. PubMed ID: 34385076
[TBL] [Abstract][Full Text] [Related]
3. Real-world use of chemotherapy for Kaposi's sarcoma in a large community-based HIV primary care system in Kenya.
Freeman EE; Busakhala N; Regan S; Asirwa FC; Wenger M; Seth D; Moon KC; Semeere A; Maurer T; Wools-Kaloustian K; Bassett I; Martin J
BMC Cancer; 2020 Jan; 20(1):71. PubMed ID: 31996161
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a Predictive Staging Model for HIV-Associated Kaposi Sarcoma in Uganda.
Okuku F; Krantz EM; Kafeero J; Kamya MR; Orem J; Casper C; Phipps W
J Acquir Immune Defic Syndr; 2017 Apr; 74(5):548-554. PubMed ID: 28107226
[TBL] [Abstract][Full Text] [Related]
5. A prospective ascertainment of cancer incidence in sub-Saharan Africa: The case of Kaposi sarcoma.
Semeere A; Wenger M; Busakhala N; Buziba N; Bwana M; Muyindike W; Amerson E; Maurer T; McCalmont T; LeBoit P; Musick B; Yiannoutsos C; Lukande R; Castelnuovo B; Laker-Oketta M; Kambugu A; Glidden D; Wools-Kaloustian K; Martin J
Cancer Med; 2016 May; 5(5):914-28. PubMed ID: 26823008
[TBL] [Abstract][Full Text] [Related]
6. AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals.
Nasti G; Talamini R; Antinori A; Martellotta F; Jacchetti G; Chiodo F; Ballardini G; Stoppini L; Di Perri G; Mena M; Tavio M; Vaccher E; D'Arminio Monforte A; Tirelli U;
J Clin Oncol; 2003 Aug; 21(15):2876-82. PubMed ID: 12885804
[TBL] [Abstract][Full Text] [Related]
7. Gender differences in clinical presentation and outcomes of epidemic Kaposi sarcoma in Uganda.
Phipps W; Ssewankambo F; Nguyen H; Saracino M; Wald A; Corey L; Orem J; Kambugu A; Casper C
PLoS One; 2010 Nov; 5(11):e13936. PubMed ID: 21103057
[TBL] [Abstract][Full Text] [Related]
8. Excellent clinical outcomes and retention in care for adults with HIV-associated Kaposi sarcoma treated with systemic chemotherapy and integrated antiretroviral therapy in rural Malawi.
Herce ME; Kalanga N; Wroe EB; Keck JW; Chingoli F; Tengatenga L; Gopal S; Phiri A; Mailosi B; Bazile J; Beste JA; Elmore SN; Crocker JT; Rigodon J
J Int AIDS Soc; 2015; 18(1):19929. PubMed ID: 26028156
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda.
Ziegler JL; Newton R; Katongole-Mbidde E; Mbulataiye S; De Cock K; Wabinga H; Mugerwa J; Katabira E; Jaffe H; Parkin DM; Reeves G; Weiss R; Beral V
AIDS; 1997 Nov; 11(13):1619-26. PubMed ID: 9365767
[TBL] [Abstract][Full Text] [Related]
10. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK.
Letang E; Lewis JJ; Bower M; Mosam A; Borok M; Campbell TB; Naniche D; Newsom-Davis T; Shaik F; Fiorillo S; Miro JM; Schellenberg D; Easterbrook PJ
AIDS; 2013 Jun; 27(10):1603-13. PubMed ID: 23462220
[TBL] [Abstract][Full Text] [Related]
11. Treatment and outcome of AIDS-related Kaposi sarcoma in South Africa, Malawi and Zambia: an international comparison.
Rohner E; Kasaro M; Msadabwe-Chikuni SC; Stinson K; Mohamed Z; Tweya H; Egger M; Bohlius J
Pan Afr Med J; 2017; 28():261. PubMed ID: 29881504
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of Clinical Suspicion and Pathologic Diagnosis of Kaposi Sarcoma in East Africa.
Amerson E; Woodruff CM; Forrestel A; Wenger M; McCalmont T; LeBoit P; Maurer T; Laker-Oketta M; Muyindike W; Bwana M; Buziba N; Busakhala N; Wools-Kaloustian K; Martin J
J Acquir Immune Defic Syndr; 2016 Mar; 71(3):295-301. PubMed ID: 26452066
[TBL] [Abstract][Full Text] [Related]
13. A prospective study of clinical outcomes of HIV-associated and HIV-negative Kaposi sarcoma in Uganda.
Phipps W; Adams SV; Mooka P; Kafeero J; Sekitene S; Mubiru D; Nankoma J; Namirembe C; Okoche L; Namubiru EB; Kayemba S; Baker KK; Redman MW; Casper C; Orem J; Warren EH
AIDS; 2023 Jan; 37(1):51-59. PubMed ID: 36083142
[TBL] [Abstract][Full Text] [Related]
14. Pitfalls of practicing cancer epidemiology in resource-limited settings: the case of survival and loss to follow-up after a diagnosis of Kaposi's sarcoma in five countries across sub-Saharan Africa.
Freeman E; Semeere A; Wenger M; Bwana M; Asirwa FC; Busakhala N; Oga E; Jedy-Agba E; Kwaghe V; Iregbu K; Jaquet A; Dabis F; Yumo HA; Dusingize JC; Bangsberg D; Anastos K; Phiri S; Bohlius J; Egger M; Yiannoutsos C; Wools-Kaloustian K; Martin J
BMC Cancer; 2016 Feb; 16():65. PubMed ID: 26852390
[TBL] [Abstract][Full Text] [Related]
15. Updating vital status by tracking in the community among patients with epidemic Kaposi sarcoma who are lost to follow-up in sub-Saharan Africa.
Semeere A; Freeman E; Wenger M; Glidden D; Bwana M; Kanyesigye M; Asirwa FC; Rotich E; Busakhala N; Oga E; Jedy-Agba E; Kwaghe V; Iregbu K; Adebamowo C; Jaquet A; Dabis F; Phiri S; Bohlius J; Egger M; Yiannoutsos CT; Wools-Kaloustian K; Martin J
BMC Cancer; 2017 Sep; 17(1):611. PubMed ID: 28865422
[TBL] [Abstract][Full Text] [Related]
16. Divergent clinical presentations and outcomes among children and adolescents with Kaposi sarcoma in Malawi and Tanzania.
Campbell LR; Silverstein A; Peckham-Gregory E; Kamiyango W; Villiera J; McAtee CL; Bacha JM; Kovarik CL; Mehta PS; Chanroo T; Kapesa A; Malingoti B; Mzikamanda R; Ozuah NW; Allen CE; Scheurer ME; El-Mallawany NK
HIV Med; 2023 Jun; 24(6):664-675. PubMed ID: 36627111
[TBL] [Abstract][Full Text] [Related]
17. Long-term efficacy on Kaposi's sarcoma of highly active antiretroviral therapy in a cohort of HIV-positive patients. CISIH 92. Centre d'information et de soins de l'immunodéficience humaine.
Dupont C; Vasseur E; Beauchet A; Aegerter P; Berthé H; de Truchis P; Zucman D; Rouveix E; Saiag P
AIDS; 2000 May; 14(8):987-93. PubMed ID: 10853980
[TBL] [Abstract][Full Text] [Related]
18. Change in Pattern of Secondary Cancers After Kaposi Sarcoma in the Era of Antiretroviral Therapy.
Mukhtar F; Ilozumba M; Utuama O; Cimenler O
JAMA Oncol; 2018 Jan; 4(1):48-53. PubMed ID: 28837714
[TBL] [Abstract][Full Text] [Related]
19. Telling the story of intersectional stigma in HIV-associated Kaposi's sarcoma in western Kenya: a convergent mixed-methods approach.
Collier S; Singh R; Semeere A; Byakwaga H; Laker-Oketta M; McMahon DE; Chemtai L; Grant M; Butler L; Bogart L; Bassett IV; Kiprono S; Maurer T; Martin J; Busakhala N; Freeman EE
J Int AIDS Soc; 2022 Jul; 25 Suppl 1(Suppl 1):e25918. PubMed ID: 35818882
[TBL] [Abstract][Full Text] [Related]
20. AIDS-related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee.
Krown SE; Testa MA; Huang J
J Clin Oncol; 1997 Sep; 15(9):3085-92. PubMed ID: 9294471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]